Active — Not RecruitingNot Applicable

Choroidal Response to Novel Spectacle Lens to Control Myopia Progression

Canada10 participantsStarted 2018-12-18

Plain-language summary

Diurnal variations in the thickness of the choroid have been reported in the literature, and, more recently, the role of the choroid has been studied with respect to its role in myopia (near-sightedness) progression.

Who can participate

Age range6 Years – 10 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Participating in the CPRO-1802-001 (Cypress\_SG) study at CORE * Read and signed an Assent and their parent/guardian has signed an information consent letter Exclusion Criteria: * Transient health condition which may affect the eye(s) (e.g. a common cold, active allergies, fatigue, etc;)

What they're measuring

Choroidal thickness

Timeframe: 3 years

Trial details

NCT IDNCT03818880

SponsorSightGlass Vision, Inc.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2022-04-21

View on ClinicalTrials.gov More Myopia, Progressive trials